Shots:
- Smith+Nephew has reported data from its trial assessing Cartiheal Agili-C implant vs SoC for the treatment of knee cartilage defects
- Trial showed that the Cartiheal Agili-C significantly improved knee pain & quality of life over 4yrs., with an 87% reduced risk of total knee arthroplasty or osteotomy compared to SoC
- Pts also reported improved function in daily, sport, & recreational activities at 2 & 4yrs of follow up, with benefits observed across all ages, lesion sizes, & osteoarthritis status; data to be presented at AANA 2025
Ref: GlobeNewswire |Â Image:Â Smith+Nephew
Related News:-Â J&J MedTech Reports First Patient Enrollment in FORWARD CAD trial of Shockwave Javelin Coronary IVL Catheter
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click Here for Full Press Release
